DURECT Corp (NASDAQ:DRRX)

0.6382
Delayed Data
As of 3:58pm ET
 +0.0395 / +6.60%
Today’s Change
0.36
Today|||52-Week Range
1.44
-35.27%
Year-to-Date
Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates
Aug 04 / Zacks.com - Paid Partner Content
United Therapeutics (UTHR) Q2 Earnings Lag Estimates
Aug 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.60
Today’s open0.58
Day’s range0.58 - 0.64
Volume5,236
Average volume (3 months)1,095,790
Market cap$137.8M
Data as of 3:58pm ET, 08/08/2022

Growth & Valuation

Earnings growth (last year)-139.38%
Earnings growth (this year)+8.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-53.58%
P/E ratioNM
Price/Sales15.87
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...-0.26-4.54%
SLGLSol Gel Technologies...+0.26+4.49%
----
VRCAVerrica Pharmaceutic...+0.06+1.78%
Data as of 4:00pm ET, 08/08/2022

Financials

Next reporting dateNovember 7, 2022
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$14.0M
Annual profit (last year)-$36.3M
Net profit margin-259.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cupertino, California

Forecasts